Home » Posts tagged 'Webinar'

Tag Archives: Webinar

#BRES Blencowe Resources – Investor Webinar Call

Blencowe Resources (BRES:LON), is pleased to announce that it will host a shareholder conference call and Q&A via Zoom conferencing this Wednesday 27 July 2022 at 12:00 pm UK time.

The call will be hosted by Blencowe’s CEO, Mike Ralston who will discuss the Company’s recently announced pre-feasibility study (“PFS”) and strategy moving forward.

Registration Details

Investors who have not yet registered are invited to do so using the following link:

  https://bit.ly/3oqgNxT

Shareholders who wish to do so are invited to submit questions via email to:   info@blencoweresourcesplc.com

The most recent copy of the Company’s corporate presentation can be found at the following link:   https://blencoweresourcesplc.com/presentation/

Interested investors can also sign up for the Company Newsletter here:

https://blencoweresourcesplc.com/contact/

 

**ENDS**

 

Contacts

 

Blencowe Resources Plc

 

Sam Quinn (London Director) 

 

www.blencoweresourcesplc.com

 

+44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Investor Enquiries

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha@flowcomms.com

 

 

Tavira Securities

Jonathan Evans

 

Tel: +44 (0)20 7100 5100 

jonathan.evans@tavirasecurities.com

First Equity Limited

Jason Robertson

Tel: +44 (0)20 7330 1883

jasonrobertson@firstequitylimited.com

Blencowe Resources #BRES – Investor Webinar Recording

Blencowe Resources (BRES:LON), is pleased to announce that a recording of the Investor Webinar, held on 24 February 2022, has been uploaded on the Homepage and ‘Investors’ section of the Company’s website (www.blencoweresourcesplc.com).

#BRES Blencowe Resources – Rescheduling of Investor Webinar

Blencowe Resources (BRES:LON), the graphite explorer developing the Orom-Cross jumbo flake graphite project in Uganda, announces the rescheduling of the Investor Webinar hosted by CEO Mike Ralston from today Thursday 17 February 2022 to Thursday 24 February 2022 at 10:00am UK time (6:00pm WST time). Registration details remain the same and are below.

CEO Mike Ralston commented:

“Due to unforeseen circumstances we have been required to reschedule the webinar. We note the high level of interest registered for the webinar and we look forward to reconvening the webinar next week. I would invite shareholders and interested parties to submit questions in advance should they wish to do so.”

Registration Details

Please note that those who have already successfully registered need not do so again.

Investors who have not yet registered are invited to do so using the following link:

https://us02web.zoom.us/webinar/register/WN_NPAroCXpT6OQIWKP1Xox1Q  

Shareholders who wish to do so are invited to submit questions via email to info@blencoweresourcesplc.com

The most recent copy of the Company’s corporate presentation can be found at the following link:

https://blencoweresourcesplc.com/presentation/ 

Please note that on the day of the call that until the Q&A session has begun that all participants will initially be muted without audio with the exception of Company management. A recording of the call will also be made available on the Company’s website following the call.

 

**ENDS**

Contacts

Blencowe Resources Plc

Sam Quinn (London Director)

www.blencoweresourcesplc.com

info@blencoweresourcesplc.com

+44 (0)1624 681 250

 

Investor Enquiries

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha@flowcomms.com

Tavira Securities

Jonathan Evans

Tel: +44 (0)20 71005100 jonathan.evans@tavirasecurities.com

First Equity Limited

Jason Robertson

Tel: +44 (0)20 7330 1883

jasonrobertson@firstequitylimited.com

Poolbeg Pharma #POLB – Upcoming London Webinar

 

CEO of Poolbeg Pharma, will be presenting at next weeks London South East webinar. They look forward to providing updates on recent Company news.

Register to attend:

https://us02web.zoom.us/webinar/register/1716431929653/WN_ZJVzMqdWTgWYBetrouIuFg

 

Power Metal Resources #POW – London South East Investor Webinar

Power Metal Resources PLC (LON:POW) the AIM listed metals exploration and development company is pleased to announce that it will be participating in the London South East Investor Webinar in which Paul Johnson, Chief Executive Officer, will be delivering a presentation and answering questions about the Company.

The presentation will provide an overview of progress across the Company’s exploration programmes and corporate activities surrounding the Company’s business interests.

The Conference is to be held at 6pm on Tuesday 1 December 2020 and investors wishing to view this may register through the following link:

https://www.lse.co.uk/events/

For further information please visit https://www.powermetalresources.com/ or contact:

Power Metal Resources plc

Paul Johnson (Chief Executive Officer)

+44 (0) 7766 465 617

SP Angel Corporate Finance (Nomad and Joint Broker)

Ewan Leggat/Charlie Bouverat

+44 (0) 20 3470 0470

SI Capital Limited (Joint Broker)

Nick Emerson                                                                                                           

+44 (0) 1483 413 500

First Equity Limited (Joint Broker)

David Cockbill/Jason Robertson

+44 (0) 20 7330 1883

 

 

Notes to Editors:

Power Metal Resources plc (LON:POW) is an AIM listed metals exploration and development company seeking a large scale metal discovery.

The Company has a global portfolio of project interests including precious metal exploration in North America and Australia together with base metal exploration in Africa. Project interests range from early stage greenfield exploration to later stage prospects currently subject to drill programmes.

The Board and its team of advisors have expertise in project generation, exploration and development and have identified an opportunity to utilise the Company’s position to become a leader in the London market for investors wishing to gain exposure to proactive global metals exploration.

Open Orphan #ORPH – Value the Markets Webinar

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that the Company will be hosting a webinar for investors at 7pm on Tuesday 11th February. For those wishing to join the event the participant details are below.

Join via Website: https://vtm.clickmeeting.com/orph

Join via Phone: +44 (20) 7048-4146

When prompted please provide the Participant’s PIN code 159543# followed by the # key

For further information please contact

Open Orphan plc

Cathal Friel, Executive Chairman              

Trevor Phillips, Chief Executive Officer

 

+353 (0)1 644 0007

+44 (0)20 7347 5350

Arden Partners plc (Nominated Adviser and Joint Broker)

John Llewellyn-Lloyd / Benjamin Cryer

+44 (0)20 7614 5900

Davy (Euronext Growth Adviser and Joint Broker)

Anthony Farrell

+353 (0)1 679 6363

Camarco (Financial PR)

Tom Huddart / Daniel Sherwen

+44 (0)20 3757 4980

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

Notes to Editors:

Open Orphan is a rapidly growing European full pharmaceutical services company with a focus on orphan drug and specialist services, comprising two commercial specialist CRO services businesses (Venn and hVIVO) and a developing early stage orphan drug genomics data platform business capturing valuable genetic data from patient populations with specific diseases with designated orphan drug status and incorporating AI tools.  In June 2019, Open Orphan acquired AIM-listed Venn Life Sciences Holdings plc in a reverse take-over and in January 2020 it completed the Merger with hVIVO plc. Venn, as an integrated drug development consultancy, offers CMC (chemistry, manufacturing and controls) , preclinical, phase I & II clinical trials design and execution. hVIVO, is a world leader in the provision of viral challenge studies, vaccine and viral laboratory services, supporting product development for customers developing antivirals, vaccines and respiratory therapeutics, all particularly relevant and topical in the environment of heightened awareness of the Coronavirus in 2020. The Merger with hVIVO created a European full pharma services company broadening the Company’s customer base and with complementary specialist CRO services, widened the range of the Company’s service offerings.

Open Orphan’s (ORPH) Maurice Treacy Hosts Value the Markets Webinar

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that the Company’s Chief Commercial Officer, Maurice Treacy, will be hosting a webinar alongside Value the Markets on Wednesday 30th October 2019 at 19:00 (UK time).

Maurice Treacy will take the opportunity to update existing and potential shareholders on Open Orphan and will provide an insight on the Company’s Genomic Health Data platform, Europe’s first rare disease, advocacy-led genomic database. Maurice will also discuss how and why it is now so important for pharmaceutical companies to have access to patient data when developing new drugs.

For those wishing to join, the webinar will be available through webcast or dial-in facilities via the details provided below:

Webcast URL Link:

https://vtm.clickmeeting.com/orph 

Dial-in details:

UK dial-in number: +44 (20) 7048 4146

Irish dial-in number: +353 (76) 680 3062

 

Participant PIN: 214883#

When prompted, please provide participant’s pin code followed by # key

 

Enquiries:

Open Orphan Plc Tel: +353 (0)1 6440007
Cathal Friel, Chief Executive Officer

Arden Partners (Nominated Adviser and Joint Broker) Tel: +44 (0)20 7614 5900
John Llewellyn-Lloyd / Ruari McGirr / Benjamin Cryer

Davy (Euronext Growth Adviser and Joint Broker) Tel: +353 (0)1 679 6363
Anthony Farrell (Corporate Finance)

Camarco (Financial PR) Tel: +44 (0)20 3757 4980
Tom Huddart / Billy Clegg / Daniel Sherwen

Notes to Editors:

Open Orphan plc is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services business. Open Orphan has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database and a Virtual Rep platform enabling pharmaceutical companies to engage key opinion leaders and physicians. The Company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.